Federal Register / Vol. 89, No. 17 / Thursday, January 25, 2024 / Notices 4949 

the Fourth Report and Order, which will 

validate technologies intended for 

indoor location. The test bed is 

necessary for the compliance 

certification framework adopted in the 

Fourth Report and Order. 

Section 9.10(i)(3)(ii) requires that 

beginning 18 months from the effective 

date of the rules, CMRS providers 

providing service in any of the six Test 

Cities identified by ATIS (Atlanta, 

Denver/Front Range, San Francisco, 

Philadelphia, Chicago, and Manhattan 

Borough of New York City) or portions 

thereof must collect and report aggregate 

data on the location technologies used 

for live 911 calls. Nationwide CMRS 

providers must submit call data on a 

quarterly basis; non-nationwide CMRS 

providers need only submit this data 

every six months. Non-nationwide 

providers that do not provide service in 

any of the Test Cities may satisfy this 

requirement by collecting and reporting 

data based on the largest county within 

the carrier’s footprint. This reporting 

requirement is necessary to validate and 

verify the compliance certifications 

made by CMRS providers. 

The Commission developed a 

reporting template to assist CMRS 

providers in collecting, formatting, and 

submitting aggregate live 911 call data 

in accordance with the requirements in 

the rules. The template will also assist 

the Commission in evaluating the 

progress CMRS providers have made 

toward meeting the 911 location 

accuracy benchmarks. The template is 

an Excel spreadsheet and will be 

available for downloading on the 

Commission’s website. The Commission 

may also develop an online filing 

mechanism for these reports in the 

future. 

Section 9.10(i)(3)(iii) requires CMRS 

providers to retain testing and live call 

data gathered pursuant to this section 

for a period of 2 years. 

Section 9.10(i)(4)(i) provides that no 

later than 18 months from the effective 

date of the adoption of the rule, 

nationwide CMRS providers shall report 

to the Commission their initial plans for 

meeting the indoor location accuracy 

requirements of paragraph (i)(2) of 

Section 9.10. Non-nationwide CMRS 

providers will have an additional 6 

months to submit their implementation 

plan. 

Section 9.10(i)(4)(ii) requires that no 

later than 18 months from the effective 

date, each CMRS provider shall submit 

to the Commission a report on its 

progress toward implementing 

improved indoor location accuracy. 

Non-nationwide CMRS providers will 

have an additional 6 months to submit 

their progress reports. All CMRS 

providers shall provide an additional 

progress report no later than 36 months 

from the effective date of the adoption 

of this rule. The 36-month reports shall 

indicate what progress the provider has 

made consistent with its 

implementation plan. 

Section 9.10(i)(4)(iii) requires that 

prior to activation of the NEAD but no 

later than 18 months from the effective 

date of the adoption of this rule, the 

nationwide CMRS providers shall file 

with the Commission and request 

approval for a security and privacy plan 

for the administration and operation of 

the NEAD. 

Section 9.10(i)(4)(iv) requires CMRS 

providers to certify ‘‘that neither they 

nor any third party they rely on to 

obtain dispatchable location 

information will use dispatchable 

location information or associated data 

for any non-911 purpose, except with 

prior express consent or as otherwise 

required by law.’’ In addition, ‘‘[t]he 

certification must state that CMRS 

providers and any third party they rely 

on to obtain dispatchable location 

information will implement measures 

sufficient to safeguard the privacy and 

security of dispatchable location 

information.’’ As noted above, the 

Commission has revised this 

requirement to account for the fact that 

the NEAD has been discontinued. 

Section 9.10(i)(4)(v) requires that 

prior to use of z-axis information to 

meet the Commission’s location 

accuracy requirements, CMRS providers 

must certify ‘‘that neither they nor any 

third party they rely on to obtain z-axis 

information will use z-axis information 

or associated data for any non-911 

purpose, except with prior express 

consent or as otherwise required by 

law.’’ Further, ‘‘[t]he certification must 

state that CMRS providers and any third 

party they rely on to obtain z-axis 

information will implement measures 

sufficient to safeguard the privacy and 

security of z-axis location information.’’ 

This requirement is necessary to ensure 

the privacy and security of any 

personally identifiable information that 

may be collected by the CMRS provider. 

As noted above, the Commission has 

revised this requirement to account for 

the fact that the NEAD has been 

discontinued. 

Section 9.10(j) requires CMRS 

providers to provide standardized 

confidence and uncertainty (C/U) data 

for all wireless 911 calls, whether from 

outdoor or indoor locations, on a percall basis upon the request of a PSAP. 

This requirement makes the use of C/U 

data easier for PSAPs. 

Section 9.10(j)(4) also requires that 

upon meeting the timeframes pursuant 

to paragraphs (i)(2)(ii)(C) and (D) of this 

section, CMRS providers shall provide 

with wireless 911 calls that have 

dispatchable location or z-axis (vertical) 

information the C/U data required under 

paragraph (j)(1) of this section. Where 

available to the CMRS provider, floor 

level information must be provided with 

associated C/U data in addition to z-axis 

location information. 

Section 9.10(k) requires CMRS 

providers to record information on all 

live 911 calls, including but not limited 

to the positioning source method used 

to provide a location fix associated with 

the call, as well as confidence and 

uncertainty data. This information must 

be made available to PSAPs upon 

request, as a measure to promote 

transparency and accountability for this 

set of rules. 

Federal Communications Commission. 

Marlene Dortch, 

Secretary, Office of the Secretary. 

[FR Doc. 2024–01480 Filed 1–24–24; 8:45 am] 

BILLING CODE 6712–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–R–262 and 

CMS–10769] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 


khammond on DSKJM1Z7X2PROD with NOTICES
4950 Federal Register / Vol. 89, No. 17 / Thursday, January 25, 2024 / Notices 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by February 26, 2024. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain . Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires Federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved Information Collection; Title 

of Information Collection: CMS Plan 

Benefit Package (PBP) and Formulary 

CY 2025; Use: Under the Medicare 

Modernization Act (MMA), Medicare 

Advantage (MA) and Prescription Drug 

Plan (PDP) organizations are required to 

submit plan benefit packages for all 

Medicare beneficiaries residing in their 

service area. The plan benefit package 

submission consists of the Plan Benefit 

Package (PBP) software, formulary file, 

and supporting documentation, as 

necessary. MA and PDP organizations 

use the PBP software to describe their 

organization’s plan benefit packages, 

including information on premiums, 

cost sharing, authorization rules, and 

supplemental benefits. They also 

generate a formulary to describe their 

list of drugs, including information on 

prior authorization, step therapy, 

tiering, and quantity limits. 

CMS requires that MA and PDP 

organizations submit a completed PBP 

and formulary as part of the annual 

bidding process. During this process, 

organizations prepare their proposed 

plan benefit packages for the upcoming 

contract year and submit them to CMS 

for review and approval. CMS uses this 

data to review and approve the benefit 

packages that the plans will offer to 

Medicare beneficiaries. This allows 

CMS to review the benefit packages in 

a consistent way across all submitted 

bids during with incredibly tight 

timeframes. This data is also used to 

populate data on Medicare Plan Finder, 

which allows beneficiaries to access and 

compare Medicare Advantage and 

Prescription Drug plans. Form Number: 

CMS–R–262 (OMB control number: 

0938–0763); Frequency: Yearly; 

Affected Public: Private Sector, Business 

or other for-profits and Not-for-profit 

institutions; Number of Respondents: 

825; Total Annual Responses: 8,770; 

Total Annual Hours: 55,782 (For policy 

questions regarding this collection 

contact Kristy Holtje at 410–786–2209.) 

2. Type of Information Collection 

Request: Revision of a currently 

approved information collection; Title 

of Information Collection: Satisfaction 

of Nursing Homes, Hospitals, and 

Outpatient Clinicians Working with the 

CMS Network of Quality Improvement 

and Innovation Contractors Program 

(NQIIC); Use: The purpose of this 

Information Collection Request (ICR) is 

to collect data to inform the program 

evaluation of the Centers for Medicare & 

Medicaid Services (CMS) Quality 

Innovation Network-Quality 

Improvement Organization (QIN–QIO) 

and Hospital Quality Improvement 

Contractors (HQIC) programs under the 

Network of Quality Improvement and 

Innovation Contractors (NQIIC) contract 

vehicle. This is a revision package. First, 

we updated the Nursing Home and 

Hospital Surveys to cover all the quality 

improvement focus areas targeted by 

NQIIC awardees, removed some but not 

all COVID–19 Public Health Emergency 

(PHE) related questions to reflect the 

progress of Federal health program (e.g., 

Agency for Healthcare Research and 

Quality Project Echo program was 

officially ended in August 2021), and 

made minor refinements based on the 

first round of survey fielding. Second, 

we added the Outpatient Clinician 

Survey in the same revision package 

since all three surveys are conducted 

under the same NQIIC contract. 

This revision package supports 

evaluation of the technical assistance 

provided by the QINQIO Program to 

nursing homes and outpatient clinicians 

in community settings, and Hospital 

Quality Improvement Contractors 

(HQIC) Program activities to support 

hospitals. This ICR is part of a larger 

evaluation of the overall impact of the 

NQIIC Program. Form Number: CMS– 

10769 (OMB control number: 0938– 

1424); Frequency: Yearly; Affected 

Public: State and Private Sector 

(Business or other for-profits); Number 

of Respondents: 1,900; Total Annual 

Responses: 1,900; Total Annual Hours: 

559. (For policy questions regarding this 

collection, contact Jeff Mokry at 214– 

767–4021.) 

Dated: January 19, 2024. 

William N. Parham, III, 

Director, Division of Information Collections 

and Regulatory Impacts, Office of Strategic 

Operations and Regulatory Affairs. 

[FR Doc. 2024–01383 Filed 1–24–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2023–N–5706] 

Voluntary Quality Management 

Maturity Prototype Assessment 

Protocol Evaluation Program 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing an opportunity for a limited 

number of establishments to participate 

in a voluntary Quality Management 

Maturity Prototype Assessment Protocol 

Evaluation Program involving the use of 

a prototype assessment protocol to 

evaluate quality management maturity 

(QMM). The Center for Drug Evaluation 

and Research (CDER) is implementing 

this voluntary program for 

manufacturers of CDER-regulated drug 

products to gain experience with the 

prototype assessment protocol and to 

evaluate whether use of the protocol, as 

designed, will enable a meaningful 

assessment of the establishment’s 


khammond on DSKJM1Z7X2PROD with NOTICES